Table-V.
Univariate analysis of risk factors for BSIs.
| Risk factors | OR (95%CI) | P value |
|---|---|---|
| Demographic characteristics | ||
| Age, years | 1.000 (0.970–1.032) | 0.980 |
| Female gender | 1.051 (0.352–3.135) | 0.929 |
| Smoker | 1.462 (0.456–4.685) | 0.523 |
| Primary disease | ||
| Myocarditis | 0.788 (0.271–2.289) | 0.661 |
| Respiratory failure | 1.400 (0.368–5.332) | 0.622 |
| Coronary artery disease | 1.314 (0.414–4.171) | 0.644 |
| Laboratory findings (Pre-ECMO) | ||
| White blood cell (103/mm3) | 1.033 (0.963–1.108) | 0.366 |
| Hemoglobin, g/L | 0.998 (0.978–1.019) | 0.880 |
| Platelets (103/mm3) | 0.999 (0.994–1.004) | 0.708 |
| Lactate, mM | 1.038 (0.931–1.158) | 0.501 |
| Total bilirubin, μM | 1.017 (0.994–1.041) | 0.152 |
| Creatinine, μM | 1.006 (0.998–1.014) | 0.117 |
| CRP mg/dL | 1.007 (0.998–1.016) | 0.122 |
| Pre-ECMO data | ||
| Pre-ECMO CPR | 1.912 (0.650–5.626) | 0.239 |
| Veno-venous ECMO mode | 1.400 (0.368–5.332) | 0.622 |
| Pre-ECMO SOFA score | 1.174 (1.039–1.326) | 0.010 |
| Pre-ECMO ICU stay ≥1 day | 1.462 (0.456–4.685) | 0.523 |
| Pre-ECMO ventilator duration ≥1 day | 2.303 (0.753–7.047) | 0.144 |
| Pre-ECMO hospital stay ≥1 day | 0.926 (0.318–2.694) | 0.887 |
| Pre-ECMO GCS | 0.982 (0.886–1.088) | 0.727 |
| MRSA prophylactic regimen | 3.162 (1.053–9.502) | 0.040 |
| During -ECMO data | ||
| IABP during ECMO | 2.070 (0.683–6.271) | 0.198 |
| CRRT during ECMO | 3.048 (1.018–9.124) | 0.046 |
| Corticosteroid before and during ECMO, mg | 1.000 (0.999–1.001) | 0.877 |
| ECMO support duration, days | 1.103 (1.003–1.212) | 0.043 |
| Before ECMO weaning data | ||
| ventilator duration before ECMO weaning, days | 1.109 (1.021–1.206) | 0.014 |
| Prognosis | ||
| ECMO weaning (Success) | 0.429 (0.134–1.369) | 0.153 |
| hospital stay, days | 1.065 (1.005–1.129) | 0.034 |
| Survival-to-discharge rate | 0.708 (0.240–2.091) | 0.532 |